Thursday, January 17, 2019
Conversion of in Vitro Fertilization Cycles to Intrauterine Inseminations in Patients With a Poor Ovarian Response to Stimulation
The purpose of this study is to compare the efficiency of conversion to IUI and IVF in patients with a poor ovarian response to stimulation
Detailed Study Description
In 5 to 10% of in vitro fertilization (IVF) cycles, a poor response to ovarian stimulation (defined as less than 4 mature follicles) is noted, even though high doses of exogenous gonadotropins are used. To date, there is no consensus on the ideal management strategy in poor responders. There are three therapeutic options available nowadays:
Oocyte retrieval is performed and the IVF cycle continued, despite the low number of mature follicles.
Conversion of the IVF cycle to an intrauterine insemination (IUI), on the condition of having at least one patent fallopian tube and good semen parameters.
Cancelation of the IVF cycle. In everyday practice, it is difficult for the physician to cancel the IVF cycle in the presence of 2, 3 or 4 mature follicles, especially following a lengthy stimulation.
If live birth rates were comparable between IUI and IVF, conversion to IUI would be the better option for poor responders, since it would avoid an invasive procedure (oocyte retrieval) and the associated risk of complications, and is associated with at a lower cost.
To our knowledge, no prospective randomized controlled trial comparing IVF to conversion to IUI in poor responders has been published to date. The studies published so far have been retrospective and observational, and had several methodological flaws.
Therefore, we aimed to analyze whether conversion of IVF cycles to IUI in poor responders would result in the same live birth rates as oocyte retrievals followed by embryo transfers.
MVT-602 is a Novel Fertility-Improving Drug FERTILITY in women with reproductive health problems can be improved using a new drug accordin...
ABSTRACT INTRODUCTION: During sexual stimulation, some women report the discharge of a noticeable amount of fluid from the urethra, a...
COVID vaccines and breastfeeding: what the data say Shannon Hall The vaccines do not pass through breastmilk, but antibodies do — p...
The predictive ability of a biomarker risk score beyond established risk factors may help identify women at risk of developing gestational d...